COVID-19 in Argentine teriflunomide-treated multiple sclerosis patients: First national case series.

We report COVID-19 presentation, course and outcomes in teriflunomide-treated MS patients in Argentina. Methods: descriptive, retrospective, multicentre, study that included MS patients receiving teriflunomide who developed COVID-19, with clinical follow-up at reference MS centres, also listed in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Luetic, Geraldine, Menichini, María L., Burgos, Marcos, Alonso, Ricardo, Carnero Contentti, Edgar, Carrá, Adriana, Deri, Norma, Steinberg, Judith, Rojas, Juan I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164731/
https://www.ncbi.nlm.nih.gov/pubmed/34130197
http://dx.doi.org/10.1016/j.msard.2021.103049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164731/
https://www.ncbi.nlm.nih.gov/pubmed/34130197
http://dx.doi.org/10.1016/j.msard.2021.103049

Ejemplares similares